Aduro Clean Technologies (ACT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
1 Jul, 2025Executive summary
Advanced collaboration with TotalEnergies to a new R&D phase, focusing on optimizing Hydrochemolytic technology for complex waste streams.
Progressed design of Next Generation Process (NGP), with completion targeted by year-end, and filed a new patent for BTX chemical production from waste plastics.
Strengthened operational foundation through a successful $3.52 million private placement and increased investment in research and laboratory equipment.
Engaged KCSA Strategic Communications to enhance investor relations and outreach.
Financial highlights
Q1 2025 revenue was $55,000, a 6% decrease compared to Q1 2024.
Loss from operations increased to $2,462,532 from $1,570,322 year-over-year.
Property, plant, and equipment carrying cost rose to $3.92 million, up $0.313 million, reflecting R&D investment.
Cash position stood at approximately $5.95 million as of August 31, 2024.
Outlook and guidance
Plans to complete NGP design by year-end, supporting scale-up and expanded collaborations.
Ongoing focus on strengthening capital structure and advancing technology applications.
Anticipates continued progress in customer engagement and commercial deployment discussions.
Latest events from Aduro Clean Technologies
- Innovative recycling tech enables low-cost, scalable plastic waste conversion, with strong industry traction.ACT
LD Micro Main Event XIX Investor Conference3 Feb 2026 - Q2 2026 delivered strong revenue growth and capital raise, advancing scale-up and demonstration plans.ACT
Q2 202615 Jan 2026 - Innovative recycling platform targets landfill plastics with scalable, flexible business models.ACT
H.C. Wainwright 27th Annual Global Investment Conference31 Dec 2025 - Pilot plant commissioning advanced, cash reserves grew, but revenue fell and losses widened.ACT
Q1 202630 Dec 2025 - Pilot plant progress, industry collaborations, and strong financing offset lower revenue and higher losses.ACT
Q4 202522 Sep 2025 - Revenue surged 208% year-over-year as technology and global partnerships advanced.ACT
Q4 20241 Jul 2025 - Nasdaq uplisting, new funding, and pilot plant advances drive commercialization amid revenue decline.ACT
Q2 20251 Jul 2025 - Q3 2025 saw lower revenue and higher losses, but key milestones and strong cash support growth.ACT
Q3 20251 Jul 2025